Feasibility and potential acceptability of three cervical barriers among vulnerable young women in Zimbabwe
暂无分享,去创建一个
[1] M. Gissler,et al. The Reproductive Health Report: The state of sexual and reproductive health within the European Union , 2011, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[2] J. Geddes,et al. What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.
[3] E. Bukusi,et al. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya. , 2008, Sexual health.
[4] V. Brache,et al. Comparative acceptability of the SILCS and Ortho ALL-FLEX diaphragms among couples in the Dominican Republic. , 2008, Contraception.
[5] A. van der Straten,et al. The Diaphragm and Lubricant Gel for Prevention of Cervical Sexually Transmitted Infections: Results of a Randomized Controlled Trial , 2008, PloS one.
[6] D. Celentano,et al. The role of men in women's acceptance of an intravaginal gel in a randomized clinical trial in Blantyre, Malawi: a qualitative and quantitative analysis , 2008, AIDS care.
[7] T. Raine,et al. Adolescent experiences with the vaginal ring. , 2008, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[8] S. Lees,et al. The role of partnership dynamics in determining the acceptability of condoms and microbicides , 2008, AIDS care.
[9] A. van der Straten,et al. Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe. , 2008, Contraception.
[10] C. Woodsong,et al. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi. , 2008, AIDS education and prevention : official publication of the International Society for AIDS Education.
[11] D. Serwadda,et al. Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward , 2008, The Lancet.
[12] A. Turner,et al. Evidence-Based Planning of a Randomized Controlled Trial on Diaphragm Use for Prevention of Sexually Transmitted Infections , 2008, Sexually transmitted diseases.
[13] C. Mauck,et al. A Phase I study of the functional performance, safety and acceptability of the BufferGel Duet. , 2008, Contraception.
[14] S. Luchters,et al. Secrecy, disclosure and accidental discovery: Perspectives of diaphragm users in Mombasa, Kenya , 2008, Culture, health & sexuality.
[15] M. Glymour,et al. Diaphragms and lubricant gel for prevention of HIV , 2007, The Lancet.
[16] N. Jewell,et al. Diaphragms and lubricant gel for prevention of HIV – Authors' reply , 2007, The Lancet.
[17] A. van der Straten,et al. A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe. , 2007, Contraception.
[18] N. Jewell,et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial , 2007, The Lancet.
[19] S. Luchters,et al. Acceptability of the diaphragm in Mombasa Kenya: A 6-month prospective study , 2007, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[20] S. Posner,et al. Sex preparation and diaphragm acceptability in sex work in Nairobi, Kenya. , 2006, Sexual health.
[21] P. Coffey,et al. Short-term acceptability of the PATH Woman's Condom among couples at three sites. , 2006, Contraception.
[22] C. Mauck,et al. SILCS Diaphragm: Postcoital Testing of a New Single-Size Contraceptive Diaphragm* , 2006 .
[23] D. Weiner,et al. FemCap with removal strap: ease of removal, safety and acceptability. , 2006, Contraception.
[24] A. Quayle,et al. Immunological Microenvironments in the Human Vagina and Cervix: Mediators of Cellular Immunity Are Concentrated in the Cervical Transformation Zone1 , 2005, Biology of reproduction.
[25] A. Turner,et al. Acceptability and feasibility of continuous diaphragm use among sex workers in Madagascar , 2005, Sexually Transmitted Infections.
[26] S. Posner,et al. Barrier Method Preferences and Perceptions Among Zimbabwean Women and their Partners , 2005, AIDS and Behavior.
[27] A. van der Straten,et al. Predictors of Diaphragm Use as a Potential Sexually Transmitted Disease/HIV Prevention Method in Zimbabwe , 2005, Sexually transmitted diseases.
[28] H. Rees,et al. Sexual Power and HIV Risk, South Africa , 2004, Emerging infectious diseases.
[29] N. Michael,et al. Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.
[30] S. Rosenthal,et al. Vaginal microbicides and teenagers , 2003, Current opinion in obstetrics & gynecology.
[31] L. Beckman,et al. Who continues using the diaphragm and who doesn't: implications for the acceptability of female-controlled HIV prevention methods. , 2003, Women's health issues : official publication of the Jacobs Institute of Women's Health.
[32] K. Barnhart,et al. Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourse. , 2002, Contraception.
[33] S. Farr,et al. Reducing unplanned pregnancy and abortion in Zimbabwe through postabortion contraception. , 2002, Studies in family planning.
[34] R. Anderson,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[35] N. Padian,et al. Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices , 2001, AIDS.
[36] P. Sow,et al. To stem HIV in Africa, prevent transmission to young women. , 2001, AIDS.
[37] M. Brady,et al. Assessing the acceptability, service delivery requirements, and use-effectiveness of the diaphragm in Colombia, Philippines, and Turkey. , 2001, Contraception.
[38] D. Weiner,et al. A comparative study of the safety and efficacy of FemCap, a new vaginal barrier contraceptive, and the Ortho All-Flex diaphragm. The FemCap Investigators' Group. , 1999, Contraception.
[39] L. Zaneveld,et al. Women's preferences for vaginal antimicrobial contraceptives. II. Preferred characteristics according to women's age and socioeconomic status. , 1998, Contraception.
[40] Shihata Aa. The FemCap: a new contraceptive choice , 1998 .
[41] L. Stanberry,et al. Topical Microbicides: Current Status and Research Considerations for Adolescent Girls , 1998, Sexually transmitted diseases.
[42] A. Shihata. The FemCap: a new contraceptive choice. , 1998, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[43] K. Beck,et al. Development and validation of a condom self-efficacy scale for college students. , 1991, Journal of American college health : J of ACH.
[44] Z. Stein,et al. HIV prevention: the need for methods women can use. , 1990, American journal of public health.
[45] G. Francis. Preventing Disease , 1877, Nature.